Detection of molecular residual disease in stage II and III melanoma utilizing circulating tumor DNA.

被引：0
|
作者：
Chen, Emily
Brunsgaard, Elise Kornreich
Kuzel, Timothy
Tan, Alan
机构：
[1] Rush Univ, Rush Med Coll, Chicago, IL USA
[2] Rush Univ, Med Ctr, Chicago, IL USA
[3] Northwestern Univ, Chicago, IL USA
[4] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21564
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Detection of circulating tumor cells and micrometastases in stage II, III, and IV breast cancer patients utilizing cytology and immunocytochemistry
    Fetsch, PA
    Cowan, KH
    Weng, DE
    Freifield, A
    Filie, AC
    Abati, A
    DIAGNOSTIC CYTOPATHOLOGY, 2000, 22 (05) : 323 - 328
  • [22] DETECTION phase II/III trial: Circulating tumor DNA-guided therapy for stage IIB/C melanoma after surgical resection.
    Lee, Rebecca
    Rothwell, Dominic G.
    Jackson, Richard
    Smith, Nigel
    Wong, Stephen Q.
    Kelso, Noel
    Burghel, George
    Hewitt, Chelsee
    Clarke, Harry
    Mitchell, Jackie
    Jones, Kate
    Muinonen-Martin, Andrew
    Turajlic, Samra
    Corrie, Philippa Gail
    Marais, Richard
    Middleton, Mark R.
    Dawson, Sarah-Jane
    Sandhu, Shahneen
    Dive, Caroline
    Lorigan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Circulating Tumor DNA for Monitoring Minimal Residual Disease and Early Detection of Recurrence in Early Stage Lung Cancer
    Tan, A.
    Lai, G.
    Saw, S.
    Chua, K.
    Takano, A.
    Ong, B.
    Koh, T.
    Jain, A.
    Tan, W.
    Ng, Q.
    Kanesvaran, R.
    Rajasekaran, T.
    Kalshnikova, E.
    Shchegrova, S.
    Ta, H.
    Lin, J.
    Renner, D.
    Sethi, H.
    Zimmermann, B.
    Aleshin, A.
    Lim, W.
    Tan, E.
    Skanderup, A.
    Ang, M.
    Tan, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S907 - S907
  • [24] CIRCULATING TUMOR DNA TO DETECT MINIMAL RESIDUAL DISEASE IN STAGE III COLORECTAL CANCER: MOVING TOWARDS CLINICAL IMPLEMENTATION
    Montagut, C.
    Gambardella, V.
    Cabeza-Segura, M.
    Fleitas, T.
    Cervantes, A.
    ESMO OPEN, 2022, 7 (01)
  • [25] Circulating tumor DNA (ctDNA) as sensitive and specific biomarker in stage I to III malignant melanoma
    Bohne, A. S.
    Heber, M.
    Axt, F.
    Juelg, P.
    Hutzenlaub, T.
    Truong, T.
    Lehnert, M.
    Cordts, J.
    Dazert, E.
    Terheyden, P.
    Langan, E.
    Gebhardt, C.
    Kaehler, K. C.
    von Bubnoff, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 54 - 55
  • [26] Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II-III gastric cancer
    Yuan, Shu-Qiang
    Nie, Run-Cong
    Huang, You-Sheng
    Chen, Ying-Bo
    Wang, Si-Yu
    Sun, Xiao-Wei
    Li, Yuan-Fang
    Liu, Ze-Kun
    Chen, Yan-Xing
    Yao, Yi-Chen
    Xu, Yu
    Qiu, Hai-Bo
    Liang, Yao
    Wang, Wei
    Liu, Ze-Xian
    Zhao, Qi
    Xu, Rui-Hua
    Zhou, Zhi-Wei
    Wang, Feng
    CANCER COMMUNICATIONS, 2023, 43 (12) : 1312 - 1325
  • [27] Use of circulating tumor DNA to predict survival in patients with resected high-risk stage II/III melanoma.
    Lee, Rebecca
    Gremel, Gabriela
    Marshall, Andrea
    Myers, Kevin A.
    Fisher, Nita
    Corrie, Philippa
    Dunn, Janet
    Dhomen, Nathalie
    Middleton, Mark R.
    Marais, Richard
    Lorigan, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] The application of circulating tumor DNA for minimal residual disease detection in pancreatic cancer
    Watanabe, Kazunori
    Low, Siew K.
    Chin, Yoon M.
    Chan, Hiu T.
    Nakamura, Toru
    Hirano, Satoshi
    Nakamura, Yusuke
    CANCER SCIENCE, 2022, 113 : 914 - 914
  • [29] The application of circulating tumor DNA for minimal residual disease detection in colorectal cancer
    Chan, Hiu Ting
    Nagayama, Satoshi
    Chin, Yoon Ming
    Otaki, Masumi
    Hayashi, Rie
    Fukunaga, Yosuke
    Ueno, Masashi
    Nakamura, Yusuke
    Low, Siew-Kee
    CANCER SCIENCE, 2021, 112 : 526 - 526
  • [30] Circulating tumour DNA analysis predicts relapse following resection in stage II and III melanoma
    Tan, L.
    Sandhu, S. K.
    Lee, R.
    Li, J.
    Callahan, J.
    Raleigh, J.
    Hatzimihalis, A.
    Middlehurst, P.
    Henderson, M.
    Shackleton, M.
    Haydon, A.
    Gyorki, D.
    Oudit, D.
    Hicks, R. J.
    Lorigan, P.
    McArthur, G. A.
    Marais, R.
    Wong, S. Q.
    Dawson, S-J.
    ANNALS OF ONCOLOGY, 2018, 29
12345